Shanghai, China

Jing Nian

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Other. Active years: 2017.


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:

goldMedal1 out of 834,411 
Other
 patents

Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Jing Nian in Pharmaceutical Crystallization

Introduction

Jing Nian is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of stable crystalline forms of drugs. His work focuses on improving the stability and usability of pharmaceutical compounds, which is crucial for long-term storage and industrial production.

Latest Patents

Jing Nian holds a patent for a "Stable apremilast crystalline form II free of solvate and method of making the same." This invention discloses a stable crystalline Form II of non-solvate Apremilast, along with methods for its production and pharmaceutical compositions that include this form. The patent highlights the advantages of Form II, which is more stable to temperature, light, and humidity compared to previously reported forms. The crystallization solvents used are safe and easily removable, making the preparation methods simple and suitable for industrial production.

Career Highlights

Throughout his career, Jing Nian has worked with various companies, including Utopharm Co., Ltd. His expertise in crystallization and pharmaceutical formulations has positioned him as a valuable contributor to the industry. His innovative approaches have led to advancements in drug stability and manufacturing processes.

Collaborations

Jing Nian has collaborated with notable colleagues such as Junzhi Luo and Siyuan Gao. These partnerships have fostered a collaborative environment that enhances research and development in pharmaceutical sciences.

Conclusion

Jing Nian's contributions to the field of pharmaceutical crystallization exemplify the importance of innovation in drug development. His patented work on stable crystalline forms significantly impacts the industry, ensuring safer and more effective pharmaceutical products.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…